Sun Pharmaceutical Industries Ltd.

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
    • Generic Drugs
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Able Laboratories
  • Aditya Acquisition Company
  • Antibe Therapeutics
  • Biosintez
  • Caraco Pharmaceutical Laboratories
  • Concert Pharmaceuticals
  • DUSA Pharmaceuticals
  • InSite Vision
  • Milmet Labs
  • Ocular Technologies
  • Phlox Pharma
  • Pharmalucence
  • Pola Pharma
  • Ranbaxy Laboratories
  • Solus Care
  • Sun Ophthalmics
  • Sun Pharma
  • Taro Pharmaceutical Industries.
See more in Biomedtracker

Latest on Sun Pharmaceutical Industries Ltd.

Pink Sheet

Trump Tariffs: Indian Pharma Dodges Bullet, But Sword May Remain

 
• By Vibha Ravi

US President Donald Trump has announced a general 26% reciprocal tariff on India, but a country-agnostic exemption of categories like pharmaceuticals implies that Indian pharma firms will not be direc

Scrip

Mounjaro In India: Price Differential, Window Of Opportunity

 
• By Anju Ghangurde

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

Scrip

Sun Sets Up For PD-L1 Play With Checkpoint Acquisition

 
• By Anju Ghangurde

India’s top-ranked drug maker Sun Pharmaceutical Industries has signaled growing ambitions in the oncology-dermatological segment, snapping up the US immunotherapy and targeted oncology company Checkp

Generics Bulletin

First Xarelto Generics Waved Through In The US: When Will They Launch?

 
• By Dean Rudge

Lupin and Sun Pharma’s Taro have received the first US Food and Drug Administration approvals for a generic version of Johnson & Johnson/Bayer’s blockbuster blood thinner Xarelto (rivaroxaban) – a